🐜
|
Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study.
12 auth.
F. Otsuka,
M. Kramer,
P. Woudstra,
K. Yahagi,
E. Ladich,
A. Finn,
...
R. D. de Winter,
F. Kolodgie,
T. Wight,
H. Davis,
M. Joner,
R. Virmani
|
7 |
2015 |
7 🐜
|
🐬
|
P2Y12 platelet inhibition in clinical practice
P. Damman,
P. Woudstra,
W. Kuijt,
R. D. de Winter,
S. James
|
6 |
2011 |
6 🐬
|
🐜
|
1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents.
14 auth.
M. Klomp,
M. Beijk,
C. Varma,
J. Koolen,
E. Teiger,
G. Richardt,
F. Bea,
N. van Geloven,
N. Verouden,
Y. Chan,
...
P. Woudstra,
P. Damman,
J. Tijssen,
R. D. de Winter
|
5 |
2011 |
5 🐜
|
🐜
|
Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study
117 auth.
M. Henkens,
A. Raafs,
J. A. J. Verdonschot,
M. Linschoten,
M. van Smeden,
P. Wang,
B. V. D. van der Hooft,
R. Tieleman,
M. Janssen,
R. T. ter Bekke,
M. Hazebroek,
I. V. D. van der Horst,
F. W. Asselbergs,
F. Magdelijns,
S. Heymans,
...
A. Al-Ali,
F. Al-Muhanna,
N. Al-Windy,
Y. Almubarak,
A. N. Alnafie,
M. Alshahrani,
A. Alshehri,
R. Anthonio,
F. W. Asselbergs,
A. Aujayeb,
J. T. ten Berg,
A. J. van Boxem,
G. Captur,
M. Caputo,
N. Charlotte,
P. Dark,
J. De Sutter,
C. Delsing,
H. G. Dorman,
J. Drost,
M. Emans,
J. B. Ferreira,
L. Gabriel,
W. V. van Gilst,
B. Groenemeijer,
H. Haerkens-Arends,
P. van der Harst,
B. Hedayat,
D. J. van der Heijden,
E. Hellou,
R. Hermanides,
J. Hermans-van Ast,
M. V. van Hessen,
S. Heymans,
I. V. D. van der Horst,
S. van Ierssel,
L. Jewbali,
M. Kearney,
H. V. van Kesteren,
B. Kietselaer,
A. Koning,
P. Kopylov,
A. Kuijper,
J. K. Kwakkel-van Erp,
M. M. van der Linden,
M. Linschoten,
G. Linssen,
R. Macías Ruiz,
F. Magdelijns,
F. Martens,
G. P. McCann,
P. B. van der Meer,
M. Meijs,
P. Messiaen,
P. Monraats,
L. Montagna,
A. Moriarty,
A. Mosterd,
P. Nierop,
C. V. van Ofwegen-Hanekamp,
Y. Pinto,
H. Poorhosseini,
S. Prasad,
J. Redón,
A. Reidinga,
M. Â. Ribeiro,
D. Ripley,
R. Salah,
E. Saneei,
M. Saxena,
J. Schaap,
D. Schellings,
A. Schut,
A. Shafiee,
A. Shore,
H. J. Siebelink,
M. van Smeden,
P. Smits,
R. Pisters,
E. Tessitore,
R. Tieleman,
P. Timmermans,
R. A. Tio,
F. Tjong,
C. D. den Uil,
E. V. Van Craenenbroeck,
H. V. van Veen,
T. Veneman,
D. Verschure,
J. K. de Vries,
R. M. van de Wal,
D. J. van de Watering,
I. Westendorp,
P. Westendorp,
C. Weytjens,
E. Wierda,
B. Williams,
P. Woudstra,
K. W. Wu,
R. Zaal,
A. Zaman,
P. M. van der Zee
|
5 |
2021 |
5 🐜
|
🦁
|
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
12 auth.
P. Woudstra,
D. Kalkman,
P. den Heijer,
I. Menown,
A. Erglis,
H. Suryapranata,
...
K. Arkenbout,
A. Íñiguez,
A. W. van ’t Hof,
Philippe Muller,
J. Tijssen,
R. D. de Winter
|
5 |
2016 |
5 🦁
|
🐜
|
Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.
7 auth.
N. Hoedemaker,
P. Damman,
P. Woudstra,
A. Hirsch,
F. Windhausen,
J. Tijssen,
...
R. D. de Winter
|
5 |
2017 |
5 🐜
|
🐜
|
Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure
10 auth.
R. Harskamp,
M. Beijk,
P. Damman,
W. Kuijt,
P. Woudstra,
M. Grundeken,
...
J. Kloek,
J. Tijssen,
B. D. de Mol,
R. D. de Winter
|
5 |
2013 |
5 🐜
|
🦁
|
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent
13 auth.
P. Woudstra,
M. Grundeken,
R. Kraak,
M. Hassell,
E. Arkenbout,
J. Baan,
M. Vis,
K. Koch,
J. Tijssen,
J. Piek,
...
R. D. de Winter,
J. Henriques,
J. Wykrzykowska
|
5 |
2014 |
5 🦁
|
🐜
|
Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus.
12 auth.
L. Hoebers,
B. Claessen,
P. Woudstra,
J. Hans DeVries,
J. Wykrzykowska,
M. Vis,
...
J. Baan,
K. Koch,
Jan G. Tijssen,
R. D. de Winter,
J. Piek,
José P. S. Henriques
|
5 |
2014 |
5 🐜
|